Turkina A, Vinogradova O, Lomaia E, Shatokhina E, et al. Phase-1 study of vamotinib (PF-114), a 3rd generation BCR::ABL1 tyrosine kinase-inhibitor, in chronic myeloid leukaemia. Ann Hematol 2025;104:2707-2715.
PMID: 40298994